Susan A. Stern
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Susan A. Stern has a total of 20 co-authors. Here are the top co-authors by number of shared publications:
- Alexander E. St. John
Department of Emergency Medicine, University of Washington, Seattle, WA 98195, USA
3 shared publications - Diana Chien
Emergency Medicine, Eisenhower Health, Rancho Mirage, USA
2 shared publications - Kristyn M. Ringgold
Department of Emergency Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
2 shared publications - Nathan James White
University of Washington, Seattle, Washington, USA
2 shared publications - Xu Wang
Department of Emergency Medicine, University of Washington School of Medicine, Seattle, WA 98195, USA
2 shared publications - Chang Yeop Han
Division of Metabolism, Endocrinology, and Nutrition, Department of Medicine, University of Washington, Seattle, Washington, USA
1 shared publication
Latest Publications
- 27 October 2026
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
An anti-inflammatory melanocortin fusion polypeptide augments whole blood resuscitation of hemorrhagic shock in a rodent polytrauma model
BACKGROUND: Severe trauma induces a cytokine storm that is associated with impaired resuscitation and recovery. We investigated the impact of AQB-565, an anti-inflammatory melanocortin fusion polypeptide, as a novel treatment adjunct for whole blood resuscitation of hemorrhagic shock using a rat polytrauma shock model. METHODS: Hemorrhagic shock with polytrauma was induced in 64 Sprague-Dawley rats. The rats were randomized to receive one of four intravenous treatments at 15 minutes posthemorrhage (T15): saline control, AQB-565, tranexamic acid (TXA), or combined AQB-565+ TXA. The rats were given autologous transfusion of shed whole blood at 60 minutes and as needed thereafter to achieve mean arterial pressure (MAP) of 60 mm Hg for up to 3 hours. Survival, hemodynamics, cytokine profiles, and hemorrhage volumes were compared between groups. RESULTS: There was a significant overall effect of treatment group on MAP (two-way rmANOVA p =0.02) that coincided with blood transfusion. MAP was significantly increased at T105 with AQB-565+TXA versus saline control ( p =0.046). Inflammatory plasma cytokines, including interleukin-6, were significantly decreased with AQB-565 versus control groups (ANOVA p values ≤ 0.01). Seventeen (26.6%) rats died before 3 hours. There was a trend towards increased survival for treatments containing AQB-565 versus controls that was not statistically significant (Kaplan-Meier log rank p =0.06). CONCLUSIONS: A melanocortin pathway-activating polypeptide suppressed inflammation and improved hemodynamic response to whole blood transfusion in this hemorrhagic shock model.
- 27 October 2026
- Published by Wolters Kluwer Health in Journal of Trauma and Acute Care Surgery
An anti-inflammatory melanocortin fusion polypeptide augments whole blood resuscitation of hemorrhagic shock in a rodent polytrauma model
BACKGROUND: Severe trauma induces a cytokine storm that is associated with impaired resuscitation and recovery. We investigated the impact of AQB-565, an anti-inflammatory melanocortin fusion polypeptide, as a novel treatment adjunct for whole blood resuscitation of hemorrhagic shock using a rat polytrauma shock model. METHODS: Hemorrhagic shock with polytrauma was induced in 64 Sprague-Dawley rats. The rats were randomized to receive one of four intravenous treatments at 15 minutes posthemorrhage (T15): saline control, AQB-565, tranexamic acid (TXA), or combined AQB-565+ TXA. The rats were given autologous transfusion of shed whole blood at 60 minutes and as needed thereafter to achieve mean arterial pressure (MAP) of 60 mm Hg for up to 3 hours. Survival, hemodynamics, cytokine profiles, and hemorrhage volumes were compared between groups. RESULTS: There was a significant overall effect of treatment group on MAP (two-way rmANOVA p =0.02) that coincided with blood transfusion. MAP was significantly increased at T105 with AQB-565+TXA versus saline control ( p =0.046). Inflammatory plasma cytokines, including interleukin-6, were significantly decreased with AQB-565 versus control groups (ANOVA p values ≤ 0.01). Seventeen (26.6%) rats died before 3 hours. There was a trend towards increased survival for treatments containing AQB-565 versus controls that was not statistically significant (Kaplan-Meier log rank p =0.06). CONCLUSIONS: A melanocortin pathway-activating polypeptide suppressed inflammation and improved hemodynamic response to whole blood transfusion in this hemorrhagic shock model.
- Open Access
- 23 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5484
A Multifunctional, Low-Volume Resuscitation Cocktail Improves Vital Organ Blood Flow and Hemostasis in a Pig Model of Polytrauma with Traumatic Brain Injury
The resuscitation of polytrauma with hemorrhagic shock and traumatic brain injury (TBI) is a balance between permissive hypotension and maintaining vital organ perfusion. There is no current optimal solution. This study tested whether a multifunctional resuscitation cocktail supporting hemostasis and perfusion could mitigate blood loss while improving vital organ blood flow during prolonged limited resuscitation. Anesthetized Yorkshire swine were subjected to fluid percussion TBI, femur fracture, catheter hemorrhage, and aortic tear. Fluid resuscitation was started when lactate concentration reached 3–4 mmol/L. Animals were randomized to one of five groups. All groups received hydroxyethyl starch solution and vasopressin. Low- and high-dose fibrinogen (FBG) groups additionally received 100 and 200 mg/kg FBG, respectively. A third group received TXA and low-dose FBG. Two control groups received albumin, with one also including TXA. Animals were monitored for up to 6 h. Blood loss was decreased and vital organ blood flow was improved with low- and high-dose fibrinogen compared to albumin controls, but survival was not improved. There was no additional benefit of high- vs. low-dose FBG on blood loss or survival. TXA alone decreased blood loss but had no effect on survival, and combining TXA with FBG provided no additional benefit. Pooled analysis of all groups containing fibrinogen vs. albumin controls found improved survival, decreased blood loss, and improved vital organ blood flow with fibrinogen delivery. In conclusion, a low-volume resuscitation cocktail consisting of hydroxyethyl starch, vasopressin, and fibrinogen concentrate improved outcomes compare to controls during limited resuscitation of polytrauma.
- 23 November 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (23) , 5484
Open AccessA Multifunctional, Low-Volume Resuscitation Cocktail Improves Vital Organ Blood Flow and Hemostasis in a Pig Model of Polytrauma with Traumatic Brain Injury
The resuscitation of polytrauma with hemorrhagic shock and traumatic brain injury (TBI) is a balance between permissive hypotension and maintaining vital organ perfusion. There is no current optimal solution. This study tested whether a multifunctional resuscitation cocktail supporting hemostasis and perfusion could mitigate blood loss while improving vital organ blood flow during prolonged limited resuscitation. Anesthetized Yorkshire swine were subjected to fluid percussion TBI, femur fracture, catheter hemorrhage, and aortic tear. Fluid resuscitation was started when lactate concentration reached 3–4 mmol/L. Animals were randomized to one of five groups. All groups received hydroxyethyl starch solution and vasopressin. Low- and high-dose fibrinogen (FBG) groups additionally received 100 and 200 mg/kg FBG, respectively. A third group received TXA and low-dose FBG. Two control groups received albumin, with one also including TXA. Animals were monitored for up to 6 h. Blood loss was decreased and vital organ blood flow was improved with low- and high-dose fibrinogen compared to albumin controls, but survival was not improved. There was no additional benefit of high- vs. low-dose FBG on blood loss or survival. TXA alone decreased blood loss but had no effect on survival, and combining TXA with FBG provided no additional benefit. Pooled analysis of all groups containing fibrinogen vs. albumin controls found improved survival, decreased blood loss, and improved vital organ blood flow with fibrinogen delivery. In conclusion, a low-volume resuscitation cocktail consisting of hydroxyethyl starch, vasopressin, and fibrinogen concentrate improved outcomes compare to controls during limited resuscitation of polytrauma.
- 1 September 2016
- Published by Wolters Kluwer Health in Shock
- Vol. 46 (3S) , 123-128
Self-Propelled Dressings Containing Thrombin and Tranexamic Acid Improve Short-Term Survival in a Swine Model of Lethal Junctional Hemorrhage
Hemorrhage is the leading cause of preventable death in trauma, and hemorrhage from noncompressible junctional anatomic sites is particularly difficult to control. The current standard is QuikClot Combat Gauze packing, which requires 3 min of compression. We have created a novel dressing with calcium carbonate microparticles that can disperse and self-propel upstream against flowing blood. We loaded these microparticles with thrombin and tranexamic acid and tested their efficacy in a swine arterial bleeding model without wound compression. Anesthetized immature female swine received 5 mm femoral arteriotomies to induce severe junctional hemorrhage. Wounds were packed with kaolin-based QuikClot Combat Gauze (KG), propelled thrombin-microparticles with protonated tranexamic acid (PTG), or a non-propelling formulation of the same thrombin-microparticles with non-protonated tranexamic acid (NPTG). Wounds were not compressed after packing. Each animal then received one 15 mL/kg bolus of hydroxyethyl starch solution followed by Lactated Ringer as needed for hypotension (maximum: 100 mL/kg) for up to 3 h. Survival was improved with PTG (3-h survival: 8/8, 100%) compared with KG (3/8, 37.5%) and NPTG (2/8, 25%) (P P P >0.05). Thus, in this swine model of junctional arterial hemorrhage, gauze with self-propelled, prothrombotic microparticles improved survival and 2 indicators of hemorrhagic shock when applied without compression, suggesting this capability may enable better treatment of non-compressible junctional wounds.
- 1 September 2016
- Published by Wolters Kluwer Health in Shock
- Vol. 46 (3S) , 123-128
Self-Propelled Dressings Containing Thrombin and Tranexamic Acid Improve Short-Term Survival in a Swine Model of Lethal Junctional Hemorrhage
Hemorrhage is the leading cause of preventable death in trauma, and hemorrhage from noncompressible junctional anatomic sites is particularly difficult to control. The current standard is QuikClot Combat Gauze packing, which requires 3 min of compression. We have created a novel dressing with calcium carbonate microparticles that can disperse and self-propel upstream against flowing blood. We loaded these microparticles with thrombin and tranexamic acid and tested their efficacy in a swine arterial bleeding model without wound compression. Anesthetized immature female swine received 5 mm femoral arteriotomies to induce severe junctional hemorrhage. Wounds were packed with kaolin-based QuikClot Combat Gauze (KG), propelled thrombin-microparticles with protonated tranexamic acid (PTG), or a non-propelling formulation of the same thrombin-microparticles with non-protonated tranexamic acid (NPTG). Wounds were not compressed after packing. Each animal then received one 15 mL/kg bolus of hydroxyethyl starch solution followed by Lactated Ringer as needed for hypotension (maximum: 100 mL/kg) for up to 3 h. Survival was improved with PTG (3-h survival: 8/8, 100%) compared with KG (3/8, 37.5%) and NPTG (2/8, 25%) (P P P >0.05). Thus, in this swine model of junctional arterial hemorrhage, gauze with self-propelled, prothrombotic microparticles improved survival and 2 indicators of hemorrhagic shock when applied without compression, suggesting this capability may enable better treatment of non-compressible junctional wounds.